TickerFacts.

Company research / ALGN

Align Technology Inc (ALGN)

Build a valuation ↗↓ Download CSV

SEC name ALIGN TECHNOLOGY INC · CIK 0001097149 · Nasdaq · Orthopedic, Prosthetic & Surgical Appliances & Supplies

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Align Technology Inc reported revenue of $4.03B. Revenue grew 0.9% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $4.14B.

Key ratios (year ended 2025-12-31)

67.2%
Gross margin
13.5%
Operating margin
10.2%
Net margin
10.1%
Return on year-end equity
0.9%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-08-31

Headquarters locality: San Jose · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$4.14B$4.03B$4.00B$3.86B$3.73B$3.95B$2.47B$2.41B$1.97B$1.47B$1.08B
Cost of Revenue$1.32B$1.32B$1.20B$1.16B$1.10B$1.02B$708.71M$662.90M$518.62M$356.47M$264.58M
Gross Profit$2.82B$2.71B$2.80B$2.71B$2.63B$2.94B$1.76B$1.74B$1.45B$1.12B$815.29M
R&D Expense$377.00M$369.91M$364.20M$346.83M$305.26M$250.31M$175.31M$157.36M$128.90M$97.56M$75.72M
Operating Income$547.59M$545.75M$607.63M$643.34M$642.60M$976.40M$387.17M$542.49M$466.56M$353.61M$248.92M
Depreciation & Amortization$254.39M$237.44M$145.03M$142.40M$125.79M$108.73M$93.54M$78.99M$54.73M$37.74M$24.00M
EBITDA$801.98M$783.19M$752.66M$785.74M$768.39M$1.09B$480.71M$621.48M$521.29M$391.35M$272.92M
Net Income$413.58M$410.35M$421.36M$445.05M$361.57M$772.02M$1.78B$442.78M$400.24M$231.42M$189.68M
EPS (Diluted)n/a$5.65$5.62$5.81$4.61$9.69$22.41$5.53$4.92$2.83$2.33
Total Assets$6.42B$6.23B$6.21B$6.08B$5.95B$5.94B$4.83B$2.50B$2.05B$1.78B$1.40B
Total Liabilities$2.19B$2.18B$2.36B$2.45B$2.35B$2.32B$1.60B$1.15B$799.57M$629.72M$400.76M
Shareholders' Equity$4.23B$4.05B$3.85B$3.63B$3.60B$3.62B$3.23B$1.35B$1.25B$1.15B$999.31M
Cash & Equivalents$1.10B$1.09B$1.04B$937.44M$942.05M$1.10B$960.84M$550.42M$636.90M$449.51M$389.27M
Operating Cash Flow$755.70M$593.22M$738.23M$785.78M$568.73M$1.17B$662.17M$747.27M$554.68M$438.54M$247.65M
Capital Expenditures$122.13M$102.44M$115.58M$177.72M$291.90M$401.10M$154.92M$149.71M$223.31M$195.69M$70.58M
Free Cash Flow$633.57M$490.78M$622.65M$608.06M$276.83M$771.45M$507.26M$597.56M$331.37M$242.84M$177.08M
Share Repurchases$266.93M$465.94M$352.88M$592.36M$435.04M$375.04M$0$400.00M$300.00M$103.79M$96.22M
Shares Outstanding71.25M71.36M73.85M75.08M77.27M78.71M78.86M78.43M79.78M80.04M79.55M
Weighted Average Diluted Sharesn/a72.59M74.99M76.57M78.42M79.67M79.23M80.10M81.36M81.83M81.48M
EPS (Basic)n/a$5.66$5.63$5.82$4.62$9.78$22.55$5.57$5.00$2.89$2.38

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView